Effects of citrus fruit juices on cytotoxicity and drug transport pathways of Caco-2 cell monolayers

International Journal of Pharmaceutics

Volumn 307, Issue 1, 2006, Pages 42-50

  Lim, Siok Lam ^a   Lim, Lee Yong ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Caco 2; Citrus fruit juices; Mannitol; Propranolol; Rhodamine 123; Taxonomy

Indexed keywords

CARBON 14; CITRUS FRUIT EXTRACT; GLYCOPROTEIN P; MANNITOL; PROPRANOLOL; RHODAMINE 123; TRITIUM;

ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL VIABILITY; COLON ADENOCARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DIFFUSION; DRUG ABSORPTION; DRUG EFFECT; DRUG PENETRATION; DRUG POTENTIATION; DRUG TRANSPORT; EPITHELIUM; GRAPEFRUIT JUICE; HUMAN; HUMAN CELL; ISOTOPE LABELING; LEMON JUICE; LIME (FRUIT); MONOLAYER CULTURE; ORANGE JUICE; PRIORITY JOURNAL; PUMMELO; TAXONOMY;

ABSORPTION; BEVERAGES; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CARBON RADIOISOTOPES; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CITRUS; FOOD-DRUG INTERACTIONS; HUMANS; MANNITOL; PROPRANOLOL;

EID: 28844481986     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.09.017     Document Type: Article

References (33)

1. A. Adson, P.S. Burton, T.J. Raub, C.L. Barsuhn, K.L. Audus, and N.F.H. Ho Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers J. Pharm. Sci. 84 1995 1197 1204
2. R.F. Albach, and G.H. Redman Composition and inheritance of flavanones in citrus fruit Phytochemistry 8 1969 127 143
3. B. Ameer, and R.A. Weintraub Drug interactions with grapefruit juice Clin. Pharmacokinet. 33 1997 103 121
4. D.G. Bailey, C. Munoz, J.D. Spence, and J.M.O. Arnold Interaction of citrus juices with felodipine and nifedipine Lancet 337 1991 268 269
5. H.C. Barret, and A.M. Rhodes A numerical taxonomic study of affinity relationship in cultivated Citrus and its close relatives Syst. Bot. 1 1976 105 136
6. M. Berhow, B. Tisserat, K. Kanes, and C. Vandercook Survey of phenolic compounds produced in citrus Agric. Res. Ser. Techn. Bull. Num. 1998 1856
7. M.E. Cavet, M. West, and N.L. Simmons Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells J. Pharmacol. 118 1996 1389 1396
8. G.K. Dresser, D.G. Bailey, B.F. Leake, U.I. Schwarz, P.A. Dawson, D.J. Freeman, and R.B. Kim Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine Clin. Pharmacol. Ther. 71 2002 11 20
9. V.A. Eagling, L. Profit, and D.J. Back Inhibition of the CYP 3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components Br. J. Pharmacol. 48 1999 543 552
10. Q. Guo, K. Fukuda, T. Ohta, and Y. Yamazoe Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity Drug Metab. Dispos. 28 2000 766 771
11. J. Hunter, M.A. Jepson, T. Tsuruo, N.S.L. Simmons, and B.H. Hirst Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells J. Biol. Chem. 268 1993 14991 14997
12. E.H. Kerns High throughput physicochemical profiling for drug discovery J. Pharm. Sci. 90 2001 1838 1858
13. S.-M. Kuo Transepithelial transport and accumulation of flavone in human intestinal Caco-2 cells Life Sci. 63 1998 2323 2331
14. K.S. Lown, D.G. Bailey, R.J. Fontana, S.K. Janardan, C.H. Adair, L.A. Fortlage, M.B. Brown, W. Guo, and P.B. Watkins Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A4 protein expression J. Clin. Invest. 99 1997 2545 2553
15. M. Markowska, R. Oberle, S. Juzwin, C.-P. Hsu, M. Gryszkiewicz, and A.J. Streeter Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis J. Pharmacol. Toxicol. Meth. 46 2001 51 55
16. R. Masereeuw, M.M. Moons, and F.G.M. Russel Rhodamine-123 accumulates extensively in the isolated perfused rat kidney and is secreted by the organic cation system Eur. J. Pharmacol. 321 1997 315 323
17. A. Miniscalco, J. Lundahl, C.G. Regardh, B. Edgar, and U.G. Eriksson Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice J. Pharmacol. Exp. Ther. 261 1992 1195 1199
18. A. Ohnishi, H. Matsuo, S. Yamada, H. Takanaga, S. Morimoto, Y. Shoyamo, H. Ohtani, and Y. Sawada Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4 J. Pharmacol. Exp. Ther. 293 1999 230 236
19. V. Pade, and S. Stavchansky Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model Pharm. Res. 14 1997 1210 1215
20. J. Rashid, C. McKinstry, A.G. Renwick, M. Dirnhuber, D.G. Waller, and C.F. George Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice Br. J. Clin. Pharamacol. 36 1993 460 463
21. N. Sawada, M. Murata, K. Kikuchi, M. Osanai, H. Tobioka, T. Kojima, and H. Chiba Tight junctions and human diseases Med. Electron. Microsc. 36 2003 147 156
22. D.A. Scudiero, R.H. Shoemaker, K.D. Paull, A. Monks, S. Tierney, T.H. Nofziger, M.J. Currens, D. Seniff, and M.R. Boyd Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cells lines Cancer Res. 48 1988 4827 4833
23. R. Tian, N. Koyabu, H. Takanaga, H. Matsuo, H. Ohtani, and Y. Sawada Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates Pharm. Res. 19 2002 802 809
24. M.D. Troutman, and D.R. Thakker Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells Pharm. Res. 20 2003 1192 1199
25. I.C.J. Van Der Sandt, M.C.M. Blom-Roosemalen, A.G. De Boer, and D.D. Breimer Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1: MDR1 and Caco-2 cell line Eur. J. Pharm. Sci. 11 2000 207 214
26. G. Van Meer, and K. Simons The function of tight junctions in maintaining differences in lipid composition between the apical and the basolateral cell surface domains of MDCK cells EMBO J. 5 1986 1455 1464
27. S. Violini, V. Sharma, J.L. Prior, M. Dyszlewski, and D.P. Worms Evidence for a plasma membrane-mediated permeability barrier to Tat basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate Biochemistry 41 2002 12652 12661
28. R.A. Walgren, and T. Walle The influence of plasma binding on absorption/exsorption in the Caco-2 model of human intestinal absorption J. Pharm. Pharmacol. 51 1999 1037 1040
29. P.D. Ward, T.K. Tippin, and D.R. Thakker Enhancing paracellular permeability by modulating epithelial tight junctions PSTT 3 2000 346 358
30. P.W. Wigler Cellular drug efflux and reversal therapy of cancer J. Bioenerg. Biomembr. 28 1996 279 284
31. J. Xu, M.L. Go, and L.-Y. Lim Modulation of digoxin transport across Caco-2 cell monolayers by citrus fruit juices: lime, lemon, grapefruit, and pummelo Pharm. Res. 20 2003 169 176
32. R. Yumoto, T. Murakami, Y. Nakamoto, R. Hasegawa, J. Nagai, and M. Takano Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds J. Pharmacol. Exp. Ther. 289 1999 149 155
33. J. Zastre, J. Jackson, M. Bajwa, R. Liggins, F. Iqbal, and H. Burt Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by Caco-2 cells using low molecular weight methoxypolyethylene glycol-block- polycaprolactone diblock copolymers Eur. J. Pharm. Biopharm. 54 2002 299 309